<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/247b–23" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/247b–23/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/247b–23/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_247b_23"><akn:num>247b–23</akn:num><akn:heading>National strategy and regional centers of excellence in vector-borne diseases</akn:heading><akn:content><akn:p>§ 247b–23. National strategy and regional centers of excellence in vector-borne diseases(a) In generalThe Secretary shall—(1)(A) ensure the development and implementation of a national strategy to address vector-borne diseases, including tick-borne diseases, that—(i) identifies and assesses gaps and any unnecessary duplication in federally-funded programs; and

(ii) identifies strategic goals to address such diseases and appropriate benchmarks to measure progress toward achieving such goals; and


(B) update such strategy, as appropriate; and


(2) coordinate programs and activities, including related to data collection, research, and the development of diagnostics, treatments, vaccines, and other related activities, to address vector-borne diseases, including tick-borne diseases, across the Department of Health and Human Services and with other Federal agencies or departments, as appropriate.


(b) ConsultationIn carrying out subsection (a)(1), the Secretary shall consult with the Tick-Borne Disease Working Group established under section 284s of this title and other individuals, as appropriate, such as—(1) epidemiologists with experience in vector-borne diseases;

(2) representatives of patient advocacy and research organizations that focus on vector-borne diseases, including such organizations that have demonstrated experience in related research, public health, data collection, or patient access to care;

(3) health information technology experts or other information management specialists;

(4) clinicians, entomologists, vector management professionals, public health professionals, and others with expertise in vector-borne diseases; and

(5) researchers, including researchers with experience conducting translational research.


(c) Centers of excellenceThe Secretary, in coordination with the Director of the Centers for Disease Control and Prevention, shall award grants, contracts, or cooperative agreements to institutions of higher education for the establishme</akn:p></akn:content><akn:subsection eId="subsec_247b_23_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general The Secretary shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_23_b"><akn:num>(b)</akn:num><akn:heading>Consultation</akn:heading><akn:content><akn:p>(b) Consultation In carrying out subsection (a)(1), the Secretary shall consult with the Tick-Borne Disease Working Group established under section 284s of this title and other individuals, as appropriate, such as—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_23_c"><akn:num>(c)</akn:num><akn:heading>Centers of excellence</akn:heading><akn:content><akn:p>(c) Centers of excellence The Secretary, in coordination with the Director of the Centers for Disease Control and Prevention, shall award grants, contracts, or cooperative agreements to institutions of higher education for the establishment or continued support of regional centers of excellence in vector-borne diseases to address vector-borne diseases, including tick-borne diseases, by—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_23_d"><akn:num>(d)</akn:num><akn:heading>Eligibility</akn:heading><akn:content><akn:p>(d) Eligibility To be eligible to receive a grant, contract, or cooperative agreement under subsection (c), an entity shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including a description of how the entity will conduct the activities described in such subsection.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_23_e"><akn:num>(e)</akn:num><akn:heading>Reports</akn:heading><akn:content><akn:p>(e) Reports</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_23_f"><akn:num>(f)</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>(f) Authorization of appropriations For the purpose of carrying out this section, there are authorized to be appropriated $10,000,000 for each of fiscal years 2021 through 2025.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>